We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Benitec’s Gene Silencing Technology Used by Johns Hopkins’ Scientists in the Development of a Treatment for Radio-Resistant Prostate Cancer

Product News   Jun 03, 2011

 
Benitec’s Gene Silencing Technology Used by Johns Hopkins’ Scientists in the Development of a Treatment for Radio-Resistant Prostate Cancer
FURTHER INFORMATION
 
 
 

Related Product News

Tumor Regression with New Antibody-Drug Conjugate

Product News

Iksuda Therapeutics (Iksuda), a developer of next generation Antibody Drug Conjugates (ADCs), has announced the first data on its lead ADC, IKS01.

READ MORE

Custom, Sustainable Lyophilized Products

Product News

Integrated DNA Technologies has partnered with Argonaut Manufacturing Services to provide custom, environmentally-friendly lyophilized reagents.

READ MORE

Advancing Cancer Therapy With Exosome Isolation and Detection Kits

Product News

AMSBIO have introduced a new range of reagents designed for researchers investigating targeted cancer therapy.

READ MORE

Like what you just read? You can find similar content on the communities below.

Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE